The growing number of people living with Parkinson's disease (PD), multiple sclerosis (MS) and motor neuron disease (MND) is ...

Sanofi SNY announced that it is discontinuing the phase III MOBILIZE study, which is evaluating its investigational drug, ...

A recent meta-analysis highlights the epidemiologic burden of dementia with Lewy bodies, focusing on age-related incidence and prevalence.

An expert interview explores the scientific necessity of patient experience data in amyotrophic lateral sclerosis drug ...

News and commentary from the world of neurology and neuroscience ...

For new neurology patients, seeing a physician in person or virtually made no difference in how soon they needed care next, according to an April 22 study in Neurology. The researchers used EHR data ...